Federal Health Officials Outline Plans for Temporary Availability of Select Unapproved Peptides Under Trump Administration Framework

According to two anonymous sources familiar with the matter, the Trump administration is developing a framework that would permit the temporary sale of select previously restricted peptide compounds while federal health authorities work to establish new regulatory guidelines for these controversial products.

Source link